MedPath

Biltricide

BILTRICIDE TABLETS(praziquantel)

Approved
Approval ID

d6791c7c-749a-4595-937b-32229dd59902

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 23, 2017

Manufacturers
FDA

Central Texas Community Health Centers

DUNS: 079674019

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76413-146
Application NumberNDA018714
Product Classification
M
Marketing Category
C73594
G
Generic Name
praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateAugust 23, 2017
FDA Product Classification

INGREDIENTS (9)

PRAZIQUANTELActive
Quantity: 600 mg in 1 1
Code: 6490C9U457
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Biltricide - FDA Drug Approval Details